NEW YORK (GenomeWeb) – Interpace Diagnostics said today that it has signed a national coverage agreement for its ThyGenX and ThyraMir molecular thyroid tests with Aetna.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.